| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kalvista Pharmaceuticals, Inc. (KALV) has 12 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. KALV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 462.6K | $12.49M | - | |
| Other | 223.5K | $6.03M | - | |
| Other | 142.5K | $3.85M | - | |
| Other | 100.0K | $2.70M | - | |
| Other | 51.4K | $1.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 22, 2025 | Audhya Paul K. | Chief Medical Officer | Sale+OE | 2,689 | $11.88 | $31,933.22 | -2.4% | +13.0% | +134.6% | |
| May 22, 2025 | Yea Christopher53 | Chief Development Officer | Sale+OE | 2,317 | $11.88 | $27,515.53 | -2.3% | +13.0% | +134.6% | |
| May 22, 2025 | Palleiko Benjamin L46 | Chief Executive Officer | Sale+OE | 9,999 | $11.88 | $118,743.12 | -3.2% | +13.0% | +134.6% | |
| May 19, 2025 | Yea Christopher53 | Chief Development Officer | Sale+OE | 2,600 | $11.84 | $30,791.28 | -2.6% | +10.5% | +121.8% | |
| May 19, 2025 | Palleiko Benjamin L46 | Chief Executive Officer | Sale+OE | 3,808 | $11.84 | $45,097.38 | -1.3% | +10.5% | +121.8% | |
| May 19, 2025 | Audhya Paul K. | Chief Medical Officer | Sale+OE | 2,776 | $11.84 | $32,875.61 | -2.5% | +10.5% | +121.8% | |
| Apr 9, 2025 | Venrock Healthcare Capital Partners Iii, L.P.54 | 10% Owner | Buy | 25,000 | $9.42 | $235,500.00 | +0.5% | +38.2% | +84.4% | |
| Mar 7, 2025 | Palleiko Benjamin L46 | Chief Executive Officer | Sale+OE | 6,669 | $11.97 | $79,827.93 | -2.3% | +15.8% | +35.7% | |
| Feb 24, 2025 | Audhya Paul K. | Chief Medical Officer | Sale+OE | 2,394 | $10.02 | $23,987.88 | -2.3% | +8.3% | +52.2% | |
| Feb 24, 2025 | Yea Christopher53 | Chief Development Officer | Sale+OE | 1,918 | $10.02 | $19,218.36 | -2.0% | +8.3% | +52.2% |